ISLAMABAD, Pakistan: The Policy Board of the Drug Regulatory Authority of Pakistan (DRAP) held its 51st meeting in Islamabad.
The Federal Secretary of the Ministry of National Health Services, Regulation and Coordination presided over the meeting.
The meeting was attended by expert members of the Board, Chief Executive Officer of DRAP and Directors of various Divisions of DRAP.
The Policy Board has taken a decisive step towards the provision of quality medicines and eradication of spurious/falsified drugs by directing all the pharmaceutical companies to print barcodes on the packaging of all local and imported pharmaceutical and biological drugs for human use within one month from today.
The Board also directed the DRAP to closely monitor the compliance and take all the measures including legal actions to ensure the compliance. This initiative aligns with global practices and standards, emphasizing the importance of robust supply chain management in the pharmaceutical industry.
The DRAP said that it is committed to ensuring the safety and quality of therapeutic goods in Pakistan and protecting the public from spurious and falsified products.